Published in Am J Surg on February 01, 1998
Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (LABC) | NCT00820690
Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study. World J Surg Oncol (2005) 1.34
Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study. BMC Cancer (2004) 1.14
Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations. Eur J Nucl Med Mol Imaging (2004) 0.99
Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg (2003) 0.97
Prognostic factors affecting locoregional recurrence in patients with stage IIIB noninflammatory breast cancer. World J Surg (2007) 0.81
Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer. Exp Ther Med (2011) 0.79
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944). Breast Cancer Res Treat (2008) 0.76
Utility of FDG-PET/CT in the evaluation of the response of locally advanced breast cancer to neoadjuvant chemotherapy. Int Surg (2014) 0.75
Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance. PLoS One (2017) 0.75
The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45
Genetic mapping in Bacillus subtilis. J Mol Biol (1967) 7.61
Plastic mattresses and sudden infant death syndrome. Lancet (1995) 5.59
Gene conservation in Bacillus species. I. Conserved genetic and nucleic acid base sequence homologies. Proc Natl Acad Sci U S A (1965) 4.81
The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol (2001) 4.60
Ribosomal RNA synthesis and processing in a particulate site in the HeLa cell nucleus. Science (1966) 4.43
Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol Microbiol (1999) 4.27
Bacillus sporulation gene spo0H codes for sigma 30 (sigma H). J Bacteriol (1988) 3.88
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol (1998) 3.69
Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis (2001) 3.51
Costs and benefits of cervical screening. I. The costs of the cervical screening programme. Cytopathology (1996) 3.25
Chromosomal location of DNA base sequences complementary to transfer RNA and to 5 s, 16 s and 23 s ribosomal RNA in Bacillus subtilis. J Mol Biol (1968) 3.01
SinI modulates the activity of SinR, a developmental switch protein of Bacillus subtilis, by protein-protein interaction. Genes Dev (1993) 2.77
Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. Br Med J (Clin Res Ed) (1988) 2.65
Management of women with low grade cytology: how reassuring is a normal colposcopy examination? BJOG (2014) 2.61
Characterization of a cloned Bacillus subtilis gene that inhibits sporulation in multiple copies. J Bacteriol (1986) 2.59
Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol (2000) 2.59
Transformation and transduction in Bacillus subtilis: evidence for separate modes of recombinant formation. J Mol Biol (1969) 2.56
Bacillus subtilis early sporulation genes kinA, spo0F, and spo0A are transcribed by the RNA polymerase containing sigma H. J Bacteriol (1992) 2.50
A Bacillus subtilis regulatory gene product for genetic competence and sporulation resembles sensor protein members of the bacterial two-component signal-transduction systems. Genes Dev (1990) 2.44
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J (2011) 2.36
The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages. Mol Microbiol (2001) 2.34
Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet (1992) 2.31
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet (1991) 2.26
Regulation of spo0H, a gene coding for the Bacillus subtilis sigma H factor. J Bacteriol (1991) 2.19
Electron microscopic studies of detergent-treated HeLa cell nuclei. J Mol Biol (1966) 2.19
Bacillus subtilis spo0H gene. J Bacteriol (1984) 2.18
The Arthritis and Rheumatism Council's National Repository of Family Material: pedigrees from the first 100 rheumatoid arthritis families containing affected sibling pairs. Br J Rheumatol (1994) 2.14
Assessment of pre-operative investigations of thyroglossal cysts. J R Coll Surg Edinb (1996) 2.13
Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J Clin Anesth (1995) 2.09
Pacifier use and sudden infant death syndrome: results from the CESDI/SUDI case control study. CESDI SUDI Research Team. Arch Dis Child (1999) 2.07
Spastic paraparesis after anaesthesia. Lancet (1999) 2.06
Gene conservation in Bacillus species. II. The location of genes concerned with the synthesis of ribosomal components and soluble RNA. Proc Natl Acad Sci U S A (1965) 2.04
Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb (1996) 2.00
Alcohol and driving: is the 0.05% blood alcohol concentration limit justified? Drug Alcohol Rev (1991) 1.98
Genetics and physiology of the rel system of Bacillus subtilis. Mol Gen Genet (1980) 1.95
Regulation of spo0H, an early sporulation gene in bacilli. J Bacteriol (1987) 1.94
Characterization of an iron-dependent regulatory protein (IdeR) of Mycobacterium tuberculosis as a functional homolog of the diphtheria toxin repressor (DtxR) from Corynebacterium diphtheriae. Infect Immun (1995) 1.92
Genetic mapping of antibiotic resistance in markers Bacillus subtilis. Proc Natl Acad Sci U S A (1970) 1.92
Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth (1997) 1.90
Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85
The Bacillus subtilis sin gene, a regulator of alternate developmental processes, codes for a DNA-binding protein. J Bacteriol (1991) 1.84
The Global TB Drug Facility: innovative global procurement. Int J Tuberc Lung Dis (2004) 1.81
Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register. Lancet (1987) 1.81
Sevoflurane versus desflurane for outpatient anesthesia: a comparison of maintenance and recovery profiles. Anesth Analg (1995) 1.80
Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J Gen Microbiol (1986) 1.79
Structure and expression of the Bacillus subtilis sin operon. J Bacteriol (1988) 1.79
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res (1992) 1.71
Neurological deterioration in young adults with phenylketonuria. Lancet (1990) 1.71
Models for tertiary structures. Myoglobin and lysozyme. J Chem Educ (1970) 1.70
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol (2000) 1.69
Postoperative instructions: good compliance but is the advice sound? Anaesthesia (2001) 1.69
Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea. Cochrane Database Syst Rev (2004) 1.68
Glomus tumour: an analysis of 43 patients and review of the literature. Br J Surg (1992) 1.68
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. Ann Oncol (2008) 1.66
Separation of human tissue alkaline phosphatases by electrophoresis on acrylamide disc gels. Clin Chim Acta (1968) 1.66
Transcriptional control of the iron-responsive fxbA gene by the mycobacterial regulator IdeR. J Bacteriol (1999) 1.65
Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection. Lancet (1990) 1.64
The primary structure of Bacillus subtilis and Bacillus stearothermophilus 5 S ribonucleic acids. J Biol Chem (1976) 1.64
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Transcriptional regulation of the spo0F gene of Bacillus subtilis. J Bacteriol (1986) 1.61
Isolation and characterization of low molecular weight ribonucleic acid species from Bacillus subtilis. Biochemistry (1967) 1.59
Congenital hypothyroidism detected by neonatal screening: relationship between biochemical severity and early clinical features. Arch Dis Child (1992) 1.59
Post-transcriptional control of a sporulation regulatory gene encoding transcription factor sigma H in Bacillus subtilis. Mol Microbiol (1991) 1.58
Self-expanding metal stents in the management of colorectal carcinoma--a preliminary report. Clin Radiol (1998) 1.56
Recurrent aphthae: treatment with vitamin B12, folic acid, and iron. Br Med J (1975) 1.56
Randomized trial of two physiotherapy interventions for primary care neck and back pain patients: 'McKenzie' vs brief physiotherapy pain management. Rheumatology (Oxford) (2006) 1.55
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol (2007) 1.54
Blood spots on Guthrie cards can be used for inherited tetrahydrobiopterin deficiency screening in hyperphenylalaninaemic infants. Arch Dis Child (1984) 1.53
Genomic organization of the mycobacterial sigma gene cluster. Gene (1995) 1.53
Characterization of RNA polymerase and two sigma-factor genes from Mycobacterium smegmatis. Mol Microbiol (1995) 1.49
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer (2006) 1.48
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging (2000) 1.47
An evolutionary link between sporulation and prophage induction in the structure of a repressor:anti-repressor complex. J Mol Biol (1998) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Predicting a second hip fracture. J Clin Densitom (1999) 1.47
Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet (1997) 1.46
Role of Herceptin in primary breast cancer: views from North America and Europe. Oncology (2001) 1.46
Cardiac tamponade due to central venous catheterization. J R Coll Surg Edinb (1992) 1.45
Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab (1975) 1.44
Surgical management of the septic complications of diverticular disease. Ann R Coll Surg Engl (1995) 1.44
Cloning of an early sporulation gene in Bacillus subtilis. J Bacteriol (1981) 1.44
Prophylactic ondansetron does not improve patient satisfaction in women using PCA after Caesarean section. Br J Anaesth (2001) 1.43
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. J Clin Oncol (1995) 1.43
New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet (1975) 1.42
Comparison of the direct antiglobulin rosetting reaction with the mixed antiglobulin rosetting reaction for the detection of immunoglobulin on lymphocytes. J Immunol Methods (1977) 1.42
How we do it: the Bradford grommet trainer: a model for training in myringotomy and grommet insertion. Clin Otolaryngol (2005) 1.42
Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J Biol Chem (1996) 1.41
HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. Cancer Res (2001) 1.41
Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid. Eur J Surg Oncol (1999) 1.41